| Financial Year |
March 31 2023 |
| Monetary Funds |
1,252,766,791.05 |
| Held-for-trading Financial Assets |
1,478,400.00 |
| Notes Receivable |
33,100,000.00 |
| Accounts Receivable |
291,729,051.15 |
| Advances to Suppliers |
6,459,968.32 |
| Other Receivables |
1,900,021.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
263,290,840.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
289,013.00 |
| Total Current Assets |
1,970,283,595.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
838,029,606.79 |
| Under-construction Projects |
156,068,083.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
131,018,694.62 |
| R&D expenses |
42,481,361.07 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
33,649,188.16 |
| Deferred Income Tax Assets |
19,989,693.55 |
| Other Non-Current Assets |
15,497,008.67 |
| Sub-Total of Non-Current Assets |
1,236,733,636.58 |
| Total Assets |
3,207,017,232.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
234,466,764.99 |
| Accounts Payable |
191,351,292.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,871,022.06 |
| Taxes Payable |
11,576,868.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,714,669.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
46,256.17 |
| Sub-Total of Current Liabilities |
455,398,505.84 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
663,283.80 |
| Deferred Income Tax Liabilities |
25,019,723.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,380,539.03 |
| Total Liabilities |
482,779,044.87 |
| Paid-In Capital(Or Share Stock) |
438,797,049.00 |
| Capital Surplus |
720,353,143.42 |
| Surplus Reserve |
166,911,553.47 |
| LESS:Treasury Stock |
149,280,742.76 |
| Undistributed Profits |
1,544,021,574.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,724,238,187.36 |
| Owner's Equity（Stockholder's Equity） |
2,724,238,187.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,207,017,232.23 |
